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REPORT

Conservation of structure and mechanism
by Trm5 enzymes
THOMAS CHRISTIAN, HOWARD GAMPER, and YA-MING HOU1
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA

ABSTRACT
Enzymes of the Trm5 family catalyze methyl transfer from S-adenosyl methionine (AdoMet) to the N1 of G37 to synthesize m1G37tRNA as a critical determinant to prevent ribosome frameshift errors. Trm5 is specific to eukaryotes and archaea, and it is
unrelated in evolution from the bacterial counterpart TrmD, which is a leading anti-bacterial target. The successful targeting
of TrmD requires detailed information on Trm5 to avoid cross-species inhibition. However, most information on Trm5 is
derived from studies of the archaeal enzyme Methanococcus jannaschii (MjTrm5), whereas little information is available for
eukaryotic enzymes. Here we use human Trm5 (Homo sapiens; HsTrm5) as an example of eukaryotic enzymes and
demonstrate that it has retained key features of catalytic properties of the archaeal MjTrm5, including the involvement of a
general base to mediate one proton transfer. We also address the protease sensitivity of the human enzyme upon expression in
bacteria. Using the tRNA-bound crystal structure of the archaeal enzyme as a model, we have identified a single substitution
in the human enzyme that improves resistance to proteolysis. These results establish conservation in both the catalytic
mechanism and overall structure of Trm5 between evolutionarily distant eukaryotic and archaeal species and validate the
crystal structure of the archaeal enzyme as a useful model for studies of the human enzyme.
Keywords: burst kinetics; S-adenosyl methionine; m1G37-tRNA; pH-activity profile; structure-guided mutagenesis

INTRODUCTION
The extensive base and backbone modifications present in
natural tRNAs serve to promote translational fidelity and efficiency (Bjork et al. 1999; Motorin and Helm 2010; Yi and
Pan 2011). Of the more than 100 modifications identified to
date, the m1G37 base modification is strictly conserved in evolution for tRNAs specific for leucine (CUN codons, N being
one of the four natural nucleotides), proline (CCN codons),
and one of the arginine isoacceptors (the CGG codon)
(Bjork et al. 2001). This modification is also present in mitochondria and chloroplasts and even in Mycoplasma spp., the
latter of which has one of the smallest sequenced genomes
known to date. The m1G37 modification replaces the imino
proton of N1 of guanosine with a methyl group, thus preventing base-pairing on the 3′ side of the anticodon in +1 frameshifts (Fig. 1A,B). Indeed, m1G37 is essential for cell viability;
its elimination leads to accumulation of frameshifts and delayed entry of charged tRNA to the ribosome (Bjork et al.
1989; Hagervall et al. 1993; Li and Bjork 1995). In yeast, elimination of m1G37 also promotes misacylation of tRNAAsp
with arginine (Putz et al. 1994). For eukaryotic tRNAPhe spe-
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cifically, m1G37 is the substrate for conversion to the hypermodified wybutosine via four successive reactions (Noma
et al. 2006). In archaea, m1G37 is important for synthesis of
cysteinyl-tRNACys required as a substrate for decoding cysteine codons (Hauenstein et al. 2008; Zhang et al. 2008).
While m1G37 is conserved in tRNAs, the enzymes that
catalyze its synthesis are unrelated in evolution. Eukaryotes
and archaea employ the Trm5 enzyme (Bjork et al. 2001;
Christian et al. 2004), whereas bacteria use the TrmD enzyme (Bystrom and Bjork 1982a,b). While both enzymes
use AdoMet as the methyl donor to convert G37-tRNA to
m1G37-tRNA, they are fundamentally distinct in structure
(Ahn et al. 2003; Christian et al. 2004; Goto-Ito et al. 2008,
2009), in kinetics (Christian et al. 2010b), and in substrate recognition (Christian and Hou 2007; Lahoud et al. 2011;
Sakaguchi et al. 2012). The lack of similarity between TrmD
and Trm5 has led to the suggestion that specific targeting of
TrmD, without affecting the Homo sapiens Trm5 (HsTrm5),
would be a highly attractive strategy in developing the next
generation of antibiotics (White and Kell 2004).
The potential of TrmD as a leading anti-microbial target
emphasizes the need to better understand HsTrm5 for two
reasons. First, when an inhibitor is identified for TrmD, it
must be critically evaluated against HsTrm5 to eliminate
cross-inhibition in order to ensure species-specific targeting.
However, key aspects of the evaluation remain completely
void for HsTrm5, including kinetic parameters of methyl
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FIGURE 1. Synthesis of m1G37-tRNA. (A) Trm5 catalyzes the conversion of guanosine to 1-methyl-guanosine (m1G37) in tRNA, using
AdoMet as the methyl donor. (B) The sequence and cloverleaf secondary
structure of human tRNACys, which was used as the substrate for
HsTrm5 in this study. The target G37 is circled.

transfer necessary for analysis of cross-inhibition and a structural model of the enzyme for modeling and identification of
potential cross-reacting chemical groups of inhibitors. This
lack of information is hindering the development of inhibitors
into drugs. Second, given the importance of Trm5 in maintaining tRNA translational fidelity, it is essential that fundamental knowledge of the enzyme in human cells be made
readily available. However, in the only report on HsTrm5
(Brule et al. 2004), the enzyme was studied using nonhuman
tRNA substrates. In general, eukaryotic Trm5 enzymes are
poorly understood. The only other eukaryotic Trm5 that has
been studied is the enzyme of Saccharomyces cerevisiae (Lee
et al. 2007), which was reported to recognize mitochondrial
initiator tRNAMet.
The major question in the study of HsTrm5, and more
broadly eukaryotic enzymes, is the relationship with their
archaeal counterparts. While eukaryotic and archaeal Trm5
enzymes are grouped as one family, the correlation between the two divisions in sequence, structure, and catalytic
mechanism is not known. At present, the archaeal MjTrm5
(Methanococcus jannaschii) is the best-characterized enzyme,
having an extensive set of kinetic data (Christian et al. 2010b)
and well-defined crystal structures, including a binary structure with sinefungin (an inactive AdoMet analog) and a ternary structure with AdoMet and tRNA (Goto-Ito et al. 2008,
2009). However, whether MjTrm5 is a valid model to study
HsTrm5 or other eukaryotic enzymes remains an open question and cannot be predicted based on sequence alone.
Indeed, a sequence alignment by T-coffee (Notredame et al.
2000) revealed only moderate homology between HsTrm5
and MjTrm5, showing 29% identity and 53% similarity, in

contrast to 80% identity and 95% similarity among TrmDs.
Also, there exist species-specific differences between archaeal and eukaryotic enzymes (Christian et al. 2010a), whose
meaning is unknown. Furthermore, purification yields of
HsTrm5 in bacteria have been noted as low (Brule et al.
2004), in contrast to high yields of MjTrm5 (Christian et al.
2004), indicating at least in part the possibility of protease
sensitivity of the human enzyme relative to the archaeal
enzyme.
Here we address the correlation between HsTrm5 and
MjTrm5 in two parts, with the first using a kinetic approach
to evaluate the conservation of catalytic properties of the
two enzymes and the second using the tRNA-bound structure
of the archaeal enzyme as a model to evaluate the overall similarity with the human enzyme. We show that, despite their
modest sequence homology, the two enzymes are fundamentally similar in both the catalytic mechanism and overall structure, suggesting that the available structures of MjTrm5 can
provide a useful model to study HsTrm5. This study provides
direct information for HsTrm5 and a framework necessary
and most relevant to human health in the anti-microbial targeting of TrmD.
RESULTS AND DISCUSSION
Protease sensitivity of HsTrm5 in Escherichia coli
HsTrm5 was expressed in Escherichia coli with a C-terminal
His tag, based on the Kazusa sequence (Nagase et al. 2000).
The Kazusa sequence differs from the annotated genomic sequence by lacking the N-terminal peptide V2LWILWRP9 of
the genomic sequence, and by containing a K394 residue instead of glutamate (numbering based on the Kazusa sequence)
(Supplemental Fig. S1) at a nonconserved position. The lack
of the N-terminal peptide was to facilitate cloning, while the
E394K substitution was in the Kazusa sequence and not an artifact. While the expression level of the recombinant HsTrm5
was high upon induction (MW: ∼60 kDa), only a small fraction was soluble, and the purity after elution from a metal resin
was poor (15%–20%) (Supplemental Fig. S2A), consistent
with a previous report (Brule et al. 2004). Further purification
of the affinity-purified enzyme on monoS, while reaching
90% homogeneity, resulted in significant losses of protein
quantity. Because the affinity-purified enzyme was as active
as the monoS-purified enzyme on the transcript of human
tRNACys as a substrate (Fig. 1B; Supplemental Fig. S2B), we
used the affinity-purified enzyme throughout this work.
Among the impurities in the affinity-purified enzyme, a
27-kDa protein was most persistent, which was also observed
upon expression of MjTrm5 in E. coli but to a lesser extent
(Christian and Hou 2007). An LC/MS/MS analysis of the
smaller protein showed that it was a degradation product, representing the C-terminal half of the protein. Detailed MS/MS
analysis showed that the cleavage sites occurred at the N terminus to M252, V254, M261, and T263 (Supplemental Fig. S3).
www.rnajournal.org
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tion of enzyme concentration in excess
of tRNA and with saturating AdoMet
kcat/Km (tRNA)
Km (AdoMet)
Km (tRNA)
kcat
revealed Kd (tRNA) of 1.8 ± 0.1 μM
(sec−1)
(μM)
(μM)
(μM−1 sec−1)
(Supplemental Fig. S4C,D), also closely
similar to the Kd (tRNA) of 1.4 ± 0.1 μM
HsTrm5
0.42 ± 0.05
0.47 ± 0.04
0.023 ± 0.003
0.05 ± 0.01
MjTrm5
1.00 ± 0.06
0.70 ± 0.03
0.017 ± 0.002
0.02 ± 0.01
of MjTrm5 (Table 2; Christian et al.
2010b). The maximum rate constant
Values for HsTrm5 were obtained from the average of at least three independent experikchem (0.09 ± 0.01 sec−1), which included
ments. Values for MjTrm5 were taken from the published work (Christian and Hou 2007).
both the pre-chemistry isomerization of
the enzyme and the chemistry of methyl
The persistent appearance of the 27-kDa protein suggested
transfer, was again similar to that of MjTrm5 (Table 2).
that the soluble fraction of HsTrm5 when expressed in E.
The Kd values of pre-steady-state assays were interpreted
coli was sensitive to proteolysis, which was one of the reasons
as the equilibrium dissociation constant, due to the rapid
for the poor yield of the enzyme relative to MjTrm5.
equilibrium binding conditions (Johnson 1998). This interpretation has been confirmed for MjTrm5, using the intrinsic
enzyme tryptophan fluorescence as a probe for equilibrium
Kinetic analysis of HsTrm5
binding of tRNA in the presence of saturating sinefungin
The affinity-purified HsTrm5 was examined for its steady(Sakaguchi et al. 2012). The addition of tRNA to the enzyme
resulted in quenching of the intrinsic fluorescence and the
state activity on the transcript of human tRNACys, similar to
the previous analysis of MjTrm5 with a transcript of the armeasurement of the quench as a function of tRNA revealed
chaeal tRNACys (Christian et al. 2004, 2010b; Sakaguchi
a Kd (tRNA) of 1.3 ± 0.6 μM, closely similar to the kinetic
Kd (tRNA) determined for MjTrm5 (1.4 ± 0.1 μM) and for
et al. 2012). The transcript of human tRNACys had a capacity
of methylation to ∼70% levels in extended time. The methylHsTrm5 (1.8 ± 0.1 μM). Based on the kinetic Kd of each enzyme as the equilibrium binding constant, the catalytic effiation reaction monitored methyl transfer from [3H-methyl]ciency of methyl kchem/Kd (tRNA) was closely similar for the
AdoMet to G37-tRNA, producing 3H-m1G37-tRNA and
releasing S-adenosyl homocysteine (AdoHcys). Steady-state
two enzymes (0.05 ± 0.01 μM−1 sec−1 for HsTrm5 and 0.09
activity as a function of AdoMet concentration with saturating
± 0.01 μM−1 sec−1 for MjTrm5).
tRNA revealed Km (AdoMet) of 0.42 ± 0.08 μM and kcat of
0.023 ± 0.003 sec−1, closely similar to values of MjTrm5 [Km
The rate-determining step
(AdoMet) of 1.0 ± 0.1 μM and kcat of 0.017 ± 0.002 sec−1]
(Table 1; Christian et al. 2006). Separately, steady-state acMjTrm5 previously showed a rapid burst of product synthesis
tivity as a function of tRNA in the presence of saturating
in a pre-steady-state assay, followed by a slower and linear synAdoMet revealed Km (tRNA) of 0.47 ± 0.04 μM and kcat/Km
thesis over time (Christian et al. 2010b). The burst suggested
(tRNA) of 0.05 ± 0.01 μM−1 sec−1, also closely similar to valthat product synthesis in the first turnover was fast, but that
ues for MjTrm5 [Km (tRNA) of 0.70 ± 0.05 μM and kcat/Km
product release from the enzyme was slow, thus limiting the
(tRNA) of 0.024 ± 0.003 μM−1 sec−1) (Table 1; Christian
rate of subsequent turnovers. In contrast, TrmD showed a
et al. 2006).
linear synthesis of product over time, suggesting that the slow
Pre-steady-state assays were also performed, with the enstep occurred before or during methyl transfer (Christian
zyme in molar excess of AdoMet and with tRNA saturating
et al. 2010b). Similar to MjTrm5, HsTrm5 also showed a rapid
to permit only one methyl transfer on the enzyme. The rate
burst of product synthesis followed by a steady-state rate
constant of each time course represented a composite term
(Fig. 2). Fitting the burst data yields kchem of 0.13 ± 0.02
for all reaction steps from enzyme-substrates binding and up
sec−1 and kcat of 0.020 ± 0.002 sec−1, similar to values deter1
to and including the formation of m G37-tRNA (Johnson
mined by separate steady-state and pre-steady-state analysis
1998). All time courses were well fit to a single exponential
(Table 1). Extrapolation of the burst plot to the ordinate yieldequation (Supplemental Fig. S4A), indicating rapid equied an estimate for the active enzyme fraction at 15%–20%,
librium binding. Control experiments
confirmed that the mixing order did
not affect the rate of methyl transfer.
TABLE 2. Pre-steady-state parameters of HsTrm5 relative to MjTrm5
Fitting the data of kobs as a function of
Kd (AdoMet) (μM) Kd (tRNA) (μM) kchem (sec−1) kchem/Kd (tRNA) (μM−1 sec−1)
enzyme concentration to a hyperbola
(Supplemental Fig. S4B) revealed the disHsTrm5
1.1 ± 0.1
1.8 ± 0.1
0.09 ± 0.01
0.05 ± 0.01
sociation constant Kd (AdoMet) (1.1 ±
MjTrm5
0.8 ± 0.1
1.4 ± 0.1
0.12 ± 0.01
0.09 ± 0.01
0.1 μM), which is closely similar to the valValues for HsTrm5 were obtained from the average of three independent experiments.
ue of MjTrm5 (Christian et al. 2010b).
Values for MjTrm5 were taken from the published work (Christian et al. 2010b).
Similarly, fitting the data of kobs as a funcTABLE 1. Steady-state parameters of HsTrm5 relative to MjTrm5
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Kinetic isotope effect

FIGURE 2. A rapid burst of product synthesis catalyzed by HsTrm5.
Time courses of m1G37-tRNA synthesis under pre-steady-state conditions, showing a rapid burst of product synthesis in the first enzyme
turnover, followed by a slower steady-state rate. Error bars represent
standard errors of three independent experiments. The rate constant
of the first enzyme turnover is shown as kchem, while that of subsequence
enzyme turnovers is shown as kcat.

which corresponds closely to the purity of the affinity-isolated
enzyme. This active-site fraction was used to correct the enzyme concentration as was done for MjTrm5 (Christian
et al. 2010b).
The pH-activity profile

While the pH-activity analysis demonstrated the importance
of one-proton transfer for catalysis, the structure of MjTrm5
did not identify an appropriately positioned general base for
proton abstraction of the N1 of G37. Instead, the general
base for MjTrm5 was proposed to be E185, which is strictly
conserved as glutamate or aspartate but is located >5 Å away
from the N1 of G37 (Christian et al. 2010a). The location of
E185 far away from the N1 of G37 suggested that proton
abstraction had occurred before the active-site structure was
captured in the crystal, most likely during the induced-fit rearrangement of the enzyme with G37 of tRNA. In this model,
the kobs represented the induced-fit process rather than the
chemical step of proton abstraction and thus would not be
sensitive to the isotope effect at the N1 of G37. This hypothesis
was confirmed for both MjTrm5 and HsTrm5 by evaluating
the kinetic isotope effect of the methyl transfer reaction, where
the N1 proton of G37 had been readily exchanged to deuterium in the presence of deuterium water (McConnell et al.
1983; Snoussi and Leroy 2001). Pre-steady-state kinetic assays
showed that kobs for MjTrm5 (0.11 sec−1) and kobs for HsTrm5
(0.012 sec−1) remained unaffected in deuterium water relative
to hydrogen water (Fig. 4A,B), indicating that the chemical
step of proton abstraction was not the rate-determining step
for these enzymes. The lack of an effect for both enzymes supports the notion that they share a common kinetic mechanism
involving proton abstraction during a slower and rate-determining process of induced fit. This induced-fit and proton
abstraction would require the action of the general base and
a conserved arginine side chain to facilitate the rearrangement of electrons (Supplemental Fig. S5).

The high pKa (∼9.5) of the N1 imino proton of G37 suggested
that enzyme-catalyzed deprotonation would be necessary for
methyl transfer. Indeed the pH-activity profile of MjTrm5
showed that catalysis was dependent on one proton transfer
(Christian et al. 2010a), most likely the transfer of the N1 proton of G37 to a general base on the enzyme. A pH-activity
Evaluation of the active-site structure
profile of HsTrm5 also revealed a steep increase of kobs as the
proton concentration was lowered, up to an asymptote at pH
The conservation of kinetic features between HsTrm5 and
MjTrm5 suggests the conservation of the active-site structure.
8.0 (Fig. 3A). We measured kobs at each pH, rather than Kd
and kchem, due to the inability to produce large quantities of
We tested this hypothesis by evaluating mutations in HsTrm5
HsTrm5. The logarithmic plot of kobs (log[kobs]) versus pH re(Table 3), based on the ternary structure of MjTrm5 (Goto-Ito
vealed a slope of 0.5 (Fig. 3B), most consistent with one proton transfer upon
deprotonation of the N1 of G37. The value
of 0.5 suggests the possibility that the kobs
of the human enzyme might be a function
of both kchem and Kd (tRNA) and that only
one of the two (probably kchem) exhibited
a dependence on pH. This is a notable difference from MjTrm5, which displayed a
value close to 1.0 (Christian et al. 2010a).
For the human enzyme, fitting the data
of kobs as a function of pH to a one-proton
transfer equation revealed a pKa of 7.1 ±
0.1 (Fig. 3A), higher by 0.6 units than the
FIGURE 3. A pH-activity profile of HsTrm5. (A) A plot of the observed rate constant kobs against
pKa of MjTrm5 (6.5 ± 0.2) (Christian pH. (B) A logarithmic plot of kobs as a function of pH from 6.0 to 9.5. Error bars represent standard errors of at least three independent experiments.
et al. 2010a).
www.rnajournal.org
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FIGURE 4. Analysis of kinetic isotope effect. (A) Kinetics of m1G37tRNA synthesis catalyzed by MjTrm5, showing a virtually identical
kobs of 0.11 sec−1 in H2O and in D2O, with standard errors of 0.02.
(B) Kinetics of m1G37-tRNA synthesis catalyzed by HsTrm5, showing
a virtually identical kobs of 0.012 sec−1 with standard errors of 0.001.
Data for H2O are shown in closed triangles; data for D2O are shown
in closed circles.

et al. 2009). Due to the limitation in enzyme quantities, we
again performed assays for HsTrm5 variants at a single enzyme concentration in excess to tRNA in the presence of saturating AdoMet. To verify the proposed mechanism, we
showed that the E288A mutation of HsTrm5, equivalent to
the E185A mutation of MjTrm5 at the general base position,
reduced kobs by ∼330-fold, similar to the reduction observed
for MjTrm5 (Christian et al. 2010a). Also, a highly conserved
aspartate residue (D172 in MjTrm5 and D275 in HsTrm5)
in the flexible loop preceding the proposed general base
(Fig. 5A,B) may be involved in the induced-fit movement of
the catalytic process. We showed that the D275A mutation
in HsTrm5 decreased kobs by 33-fold in a magnitude similar
to the 24-fold decrease by the D172A mutation of the archaeal
enzyme, supporting the notion that both enzymes engage this
aspartate likely in the movement of the general base to the
proximity of the N1 of G37.
Within the conserved active-site structure of MjTrm5 and
HsTrm5, we tested archaea- and eukaryote-specific residues.
Of interest was the residue immediately C-terminal to the proposed general base, where the R186A mutation in the archaeal
enzyme decreased kobs by 12-fold, whereas the corresponding
H289A mutation in the human enzyme had no effect. The lack
of an effect in HsTrm5 was further confirmed by the H289R
mutation, representing a switch from the eukaryote-specific
histidine to the archaea-specific arginine. Thus, while this position in the archaeal enzyme appears important, stabilizing
AdoMet binding with a charged hydrogen bond to the carboxylate of the methyl donor (Fig. 5B), it is not important for
HsTrm5. However, at other positions where archaeal versus
eukaryotic sequences differed, we found that sequence differences do not lead to a different effect on catalysis. For example,
at a position adjacent to the amino group of AdoMet (Fig.
5A), while H162 in MjTrm5 is largely conserved as histidine (∼75%) or tyrosine (∼25%) among archaeal enzymes
(Christian et al. 2010a), the corresponding K264 of HsTrm5
has a wider diversity (e.g., lysine, serine, glutamate, valine,
and isoleucine). However, we found that the H162K mutation
1196
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in the archaeal enzyme, which introduced the human lysine,
and the reciprocal K264H mutation of the human enzyme,
decreased kobs similarly by 150-fold to 180-fold, supporting
the notion that the active site of the two enzymes is generally
well conserved. Also, we showed that the K394E substitution
in HsTrm5, which reproduced the genomic sequence, had
no effect on kobs, indicating that this substitution is not deleterious for catalysis and that the enzyme produced by the Kazusa
sequence is essentially identical to that encoded by the genomic sequence.
Evaluation of the overall structure
The conservation of catalytic features between HsTrm5 and
MjTrm5, however, does not mean the conservation of their
overall structure. To probe the similarity of their overall structure, we addressed the challenge of the protease sensitivity

FIGURE 5. A structure-guided mutational analysis of HsTrm5. (A) An
overall view of the active site in the crystal structure of MjTrm5 in complex
with tRNA and AdoMet (PDB 2ZZN). All of the residues that have been
tested in MjTrm5 and the corresponding residues in HsTrm5 (shown in
parentheses) are highlighted. The G37 in the tRNA is flipped out from
stacking with the anticodon nucleotides, and its N1 is directly opposite
from the methyl group of the bound AdoMet by 2.8 Å. (B) A close-up
view of the stereochemistry of the active site in MjTrm5, showing the enzyme stabilization of the O6-carbonyl of G37 by R145 (HsR248) and stabilization of the carboxyl group of AdoMet by R186 (HsH289), allowing
the placement of the methyl group directly opposite from the N1-proton
of G37 by 2.8 Å. The catalytically important E185 (HsE288), which likely
acts as a general base, and the highly conserved D172 (HsD275), which
may participate in the movement of the general base, are both shown.

Conservation of Trm5

ity. We show here that, despite the moderate sequence similarity, HsTrm5 is
fundamentally similar to MjTrm5 in caRelative to WT kobs
kobs (sec−1)
Relative to WT kobs
talysis (Figs. 2–4; Tables 1, 2), including
WT MjTrm5 1.0
WT HsTrm5 0.09 ± 0.01
1.0
the occurrence of one-proton transfer in
L159
Not determined
M261L
0.10 ± 0.01
1/0.9
an induced-fit process of methyl transfer.
H162K
1/150
K264H
0.0006 ± 0.0001
1/180
We also show that HsTrm5 is similar to
D172A
1/24
D275A
0.0027 ± 0.0003
1/33
MjTrm5 not only in the active site (as inE185A
<1/300
E288A
0.00027 ± 0.00005
1/330
ferred from kinetic data) but also in
R186A
1/12
H289A
0.13 ± 0.02
1/0.69
R186H
Not determined
H289R
0.093 ± 0.01
1/0.97
broader regions of the overall structure
K272E
Not determined
K394E
0.09 ± 0.01
1/1
that control stability (Table 3). However,
this study also identifies two features
Values for HsTrm5 were obtained from the average of three independent experiments.
Values for MjTrm5 mutations E185A and R186A were taken from the published work
where HsTrm5 differs from MjTrm5. In
(Christian et al. 2010a), while those for mutations H162K and D172A were determined
one, the value of 0.5-proton transfer of
from the average of three independent experiments and normalized to the WT value of
−1
HsTrm5 versus one-proton transfer of
0.12 ± 0.04 sec .
MjTrm5 (Fig. 3) suggests a more complex
meaning of kobs for the human enzyme. In
the other, while the residue C-terminal to the general base plays
of the human enzyme relative to the archaeal enzyme. If
an important role for the archaeal enzyme by stabilizing the
the two enzymes share a similar structure, then a structurecarboxyl end of AdoMet (R186), it is not important for the huguided site-specific substitution in the human enzyme to
man enzyme (H289). Further studies are necessary to illumimodel the archaeal enzyme should confer an archaeal-like
nate the structural basis of these differences.
stability to the human enzyme. Because the protease-sensiAn important contribution of this study is the validative sites of the human enzymes M252, V254, M261, and
tion of the MjTrm5 ternary structure as a useful model for
T263 (Supplemental Fig. S3) are nonconserved and outside
HsTrm5. The successful utilization of the structure to remodel
of the active site, this made the modeling more challenging.
HsTrm5 for protease resistance, even at nonconserved posiModeling of these residues to the tRNA-bound structure of
tions outside of the active site, is a strong testament for the valMjTrm5 showed that, while M252 and V254 are localized in
idation. This validation of the archaeal structure is important,
a loop that stabilizes G37, M261 and T263 are in a helix
given the difficulty to obtain large quantities of HsTrm5 for
more distant from G37 (Fig. 5A). We found that, indeed, the
structural analysis. However, caution should be exercised
single M261L substitution that recapitulated the archaeal resduring modeling of the archaeal structure. For example, yeast
idue minimized the 27-kDa protease product upon enzyme
Trm5 is localized in the nucleus, where it catalyzes m1G37 synexpression in E. coli, indicating improved stability. In contrast,
thesis after tRNAPhe is modified with Cm32 and Gm34 (Nm =
the T263I substitution had no effect, whereas the double sub2′ -O-methylation in nucleotide N) in the cytoplasm and sent
stitutions (M261L and T261I) had the same effect as the single
back to the nucleus (Murthi et al. 2010). The Trm5 product
M261L substitution (Supplemental Fig. S6). Importantly, the
m1G37-tRNA is then re-exported to the cytoplasm for conversingle M261L substitution retained the full enzyme activity
sion of m1G37 to yW37 (Ohira and Suzuki 2011). Such a com(Table 3), indicating that the substitution is not involved in
plex tRNA trafficking mechanism does not exist in archaea,
catalysis but in structural stability, at least for expression in
suggesting the possibility that eukaryotic Trm5 may act on
E. coli. The successful remodeling of the human enzyme for
Cm32- and Gm34-modified tRNAPhe in a distinct G37-reexpression in E. coli, based on modeling with the archaeal
cognition mechanism relative to MjTrm5. This possibility
structure, demonstrates the overall structural similarity of
must be addressed with specific analysis of tRNAPhe and
the two enzymes and provides validation that the archaeal
with high-resolution structures of HsTrm5 in complex with
structure is a reasonable working model for studies of the hutRNAPhe and an analog of AdoMet. Because of the importance
man enzyme.
of HsTrm5, efforts to obtain its structures should be given priority in order to produce insight into how eukaryotic Trm5 is
CONCLUSION
diverged from its archaeal counterpart and how it is separated
from the bacterial TrmD.
The interest in Trm5 structure and mechanism has been high
because of its fundamental distinction from the bacterial
TrmD, which is a leading target in developing the next generMATERIALS AND METHODS
ation of antibiotics (White and Kell 2004). However, the information on HsTrm5, in particular, has been limited, thus
Cloning and expression of HsTrm5
hampering the progress of drug development against TrmD.
For HsTrm5, its moderate sequence similarity with MjTrm5
The cDNA sequence for HsTrm5 was amplified from the KIAA 1393
plasmid of Kazusa DNA Research Institute (Kisarazu, Chiba, Japan).
is not sufficient to support structural and mechanistic similarTABLE 3. Pre-steady-state parameters with respect to tRNA for wild-type (WT) and mutants
of HsTrm5
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This cDNA encodes F3 to T500 (Supplemental Fig. S1) and was
cloned into the NdeI and XhoI restriction sites of pET22b. The protein sequence as expressed starts with M1 encoded by the NdeI site,
followed by F2SGRF6 to T500, and ends with a His-tag. The coding
sequence differs from the genomic sequence (http://www.uniprot.
org/uniprot/Q32P41) by having K394 instead of E394. The recombinant enzyme was expressed in E. coli BL21(DE3)-RIL and purified
by affinity binding to the His-Link resin (Promega [V882A] in a
sonication buffer [20 mM HEPES at pH 7.5, 250 mM NaCl2, 10
mM β-mercaptoethanol, and 0.2 mM PMSF]). Mutations of the enzyme were created using the Quik-Change protocol and confirmed
by DNA sequencing analysis. Enzyme mutants were assayed in the
same way as the wild-type enzyme. Transcripts of HstRNACys were
synthesized by T7 RNA polymerase based on a DNA template created from two overlapping oligonucleotides (Zhang et al. 2008)
and were purified by a denaturing 12% PAGE/7 M urea gel.

Mass spectrometry analysis
The analysis, performed as a service at the proteomic center of Ohio
State University, is described in the legend to Supplemental Figure S3.

Kinetic assays
Steady-state kinetic assays of HsTrm5 were performed at 37°C in the
same buffer as for MjTrm5 (Christian et al. 2004). Assays for tRNA
parameters were performed with 25 μM [3H-methyl]-AdoMet (80
Ci/mmol) (PerkinElmer NET 155H), 0.25–6 μM of HstRNACys
transcript, and 50 nM of the enzyme, while those for AdoMet parameters were measured with tRNA saturated at 6 μM and 0.25–5
μM of AdoMet. Aliquots were removed at time points and precipitated in 5% TCA (trichloroacetic acid), and counts were measured
and corrected for backgrounds and a quenching efficiency of
∼55%. Parameters were determined from fitting data as a function
of concentration to the Michaelis–Menten equation. Each value was
determined from the average of at least three independent analyses,
showing standard errors, which were obtained by dividing the standard deviation of each value by the root square of the sample size.
Pre-steady-state kinetics was monitored on an RQF3 KinTek instrument (Christian et al. 2010b). One syringe contained enzyme
(0.5–10 μM) with tRNA (0.5 μM) and the other syringe contained
[3H-methyl]-AdoMet (25 μM). Data were fit to the single exponential equation:


y = yo + A × 1 − e−kapp ×t ,
where y0 is the y intercept, A is the scaling constant, kapp is the apparent or observed rate constant, and t is the time in seconds to
determine kapp. The analysis of kapp versus enzyme concentration
was fit to the hyperbolic equation:
y = kchem × Eo /(Eo + Kd ),
where kchem is the rate constant for the chemistry step, and E0 is
the enzyme concentration. Measurement of Kd (AdoMet) was as
described (Christian et al. 2010b); one syringe contained enzyme
(0.5–10 μM) with [3H-methyl]-AdoMet (0.3 μM), and the other syringe contained tRNA (6 μM). Data were fit to the single exponential
equation as above.
Burst analysis was monitored as described (Christian et al.
2010b), upon rapid mixing of HsTrm5 (1 μM) in one syringe with
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tRNA (10 μM) and 3H-AdoMet (25 μM) in the second syringe.
The data were fit to the burst equation:


y = yo + A × 1 − e−k1 ×t + k2 × Eo × t,
where y0 is the y intercept, A is the amplitude of the initial exponential phase, k1 is the apparent rate constant of the initial exponential
regression, k2 is the apparent rate constant of the steady-state phase,
and t is the time in seconds.

The pH-activity profile
The experiments were performed as described (Christian et al.
2010a). Buffers used for different pH values were as follows: sodium
cacodylate (pH 5.9, 6.1); MES (pH 6.1, 6.3, 6.4, 6.6); MOPS (pH 6.6,
6.8, 7.0, 7.1); glycyl glycine (pH 7.1, 7.3, 7.6, 8.1); and glycine (pH
9.1). If the pH was lower than the normal value, drops of 5 M KOH
were added to the 5× solution such that the 1× solution became
properly adjusted. Reactions at pH lower than 7.3 were monitored
by hand sampling, while those at higher pH values were done on
the RQF3 instrument. No differences in rate were observed for reactions run at pH values where two different buffers were used.
HsTrm5 enzyme was used at 3 μM, 37°C, in the reaction buffer
containing a final concentration of 0.1 M buffer, 0.1 M KCl, 6
mM MgCl2, 0.1 mM EDTA, 4 mM DTT, and 0.024 mg/mL BSA.
Upon rapid mixing with 0.5 μM tRNA and 25 μM AdoMet in the
same buffer, the time course of m1G37 synthesis was monitored.
Substrate saturation at pH 6.0, 8.1, and 9.8 was demonstrated by
showing that the kobs remained unchanged upon reducing the enzyme and tRNA concentrations by twofold. The consistency in the
measured kobs across all three pH values established that both
tRNA and AdoMet were stable at all relevant pH values. The data
were fit to the equation:
kobs =

kA− + kAH 10 pKa −pH
1 + 10 pKa −pH

where kobs is the observed reaction rate at a specific pH, kAH is the
activity of the protonated form of G37 (kAH = 0), kA− is the activity
of the deionized form of G37, and Ka is the equilibrium constant for
the dissociation of the proton.

Kinetic isotope effect
The solvent-exchangeable N1 imino proton of G37 in tRNA was replaced with deuterium by incubating the tRNA (previously dried
down) in D2O (Cambridge Isotope Laboratories) for a few minutes
in one syringe of RQF3. The enzyme and AdoMet were incubated in
the water-based buffer in the other syringe. Upon rapid mixing, the
time course of methyl transfer was monitored by taking aliquots and
measuring acid-precipitable counts. The kinetics of MjTrm5 was
measured at the near-saturating 6 μM of the enzyme, while that of
HsTrm5 was measured at 2 μM, due to the difficulty in obtaining
large quantities of the latter. The average value of kobs from two independent measurements was reported.

Molecular modeling
Figures were drawn with PyMol (PDB 2ZZN), corresponding to the
ternary complex of MjTrm5-tRNACys–AdoMet complex.

Conservation of Trm5

SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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